The enhanced expression of KRAS was found in tumor tissues from human subjects with HCC compared to cancer‐adjacent normal tissues, showing that the KRAS and its downstream pathways are also highly activated in HCC (Figure 1B). The gene discussed is KRAS; the disease is hepatocellular carcinoma.